The PEX gene: Not a simple answer for X-linked hypophosphataemic rickets and oncogenic osteomalacia

Molecular and Cellular Endocrinology

Volumn 132, Issue 1-2, 1997, Pages 1-5

  Nelson, Anne E ^a   Mason, Rebecca S ^a,b   Robinson, Bruce G ^a,b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

Author keywords

Hypophosphataemia; Oncogenic osteomalacia; PEX; Rickets

Indexed keywords

PROTEINASE;

GENE FUNCTION; GENE MUTATION; HUMAN; HYPOTHESIS; KIDNEY TUBULE ABSORPTION; OSTEOMALACIA; PHOSPHATE TRANSPORT; PRIORITY JOURNAL; REGULATOR GENE; REVIEW; VITAMIN D RESISTANT RICKETS; X CHROMOSOME LINKED DISORDER;

EID: 0030929550     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(97)00111-1     Document Type: Article

References (20)

1. Aschinberg, L.C., Solomon, L.M., Zeis, P.M., Justice, P., Rosenthal, I.M., 1977. Vitamin D-resistant rickets associated with epidermal nevus syndrome: demonstration of a phosphaturic substance in the dermal lesions. J. Pediatr. 91, 56-60.
2. Beck, L., Soumounou, Y., Martel, J., Krishnamurthy, G., Gauthier, C, Goodyer, C.G., Tenenhouse, H.S., 1997. Pex/PEX tissue distribution and evidence for a deletion in the 3′ region of the Pex gene in X-linked hypophosphatemic mice. J. Clin. Invest. 99, 1200-1209.
3. Cai, Q., Hodgson, S.F., Kao, P.C., Lennon, V.A., Klee, G.G., Zinsmiester, A.R., Kumar, R., 1994. Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia [see comments]. N. Engl. J. Med. 330. 1645-1649.
4. D'Adamio, L., Shipp, M.A., Masteller, E.L., Reinherz, E.L., 1989. Organization of the gene encoding common acute lymphoblastic leukemia antigen (neutral endopeptidase 24.11): multiple miniexons and separate 5′ untranslated regions. Proc. Natl. Acad. Sci. USA 86, 7103-7107.
5. Drezner, M.K., 1996. Tumor-induced rickets and osteomalacia. In: Favus, M.J. (Ed.), Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism, 3rd ed., Raven Press, New York, pp. 319-325.
6. Drezner, M.K., Lobaugh, B., Lyles, K.W., Carey, D.E., Paulson, D.E., Harrelson, J.M., 1982. The pathogenesis and treatment of tumor-induced osteomalacia. In: Norman, A.W., Schaefer, K., Herrath, D.V., Grigoleit, H.G. (Eds.), Vitamin D. Chemical, Biochemical and Clinical Endocrinology of Calcium Metabolism. Walter de Gruyter, Berlin, pp. 949-954.
7. Du, L., Desbarats, M., Viel, J., Glorieux, F.H., Cawthorn, C., Ecarot, B., 1996. cDNA cloning of the murine Pex gene implicated in X-linked hypophosphatemia and evidence for expression in bone. Genomics 36, 22-28.
8. Ecarot, B., Glorieux, F.H., Desbarats, M., Travers, R., Labelle, L., 1992. Effect of dietary phosphate deprivation and supplementation of recipient mice on bone formation by transplanted cells from normal and X-linked hypophosphatemic mice. J. Bone Miner. Res. 7, 523-530.
9. Econs, M.J., Drezner, M.K., 1994. Tumor-induced osteomalacia-unveiling a new hormone [editorial; comment]. N. Engl. J. Med. 330, 1679-1681.
10. Francis, F., Hennig, S., Korn, B., Reinhardt, R., de Jong, P., Poustka, A., Lehrach, H., Rowe, P.S.N., Goulding, J.N., Summerfield, T., Mountford, R., Read, A.P., Popowska, E., Pronicka, E., Davies, K.E., O'Riordan, J.L.H., Econs, M.J., Nesbitt, T., Drezner, M.K., Oudet, C., Pannetier, S., Hanauer, A., Strom, T.M., Meindl, A., Lorenz, B., Cagnoli, M., Mohnike, K.L., Murken. J., Meitinger, T., 1995. A gene (PEX) with homologies to endopeptidases is mutated in patients with X-linked hypophosphatemic rickets. Nat. Genet. 11, 130-136.
11. Hewison, M., 1994. Tumor-induced osteomalacia, [review]. Curr. Opin. Rheumatol. 6, 340-344.
12. Holm, I.A., Huang, X., Kunkel, L.M., 1997. Mutational analysis of the PEX gene in patients with X-linked hypophosphatemic rickets. Am. J. Hum. Genet. 60, 790-797.
13. Hruska, K.A., Rifas, L., Cheng, S.L., Gupta, A., Halstead, L., Avioli, L., 1995. X-linked hypophosphatemic rickets and the murine Hyp homologue. Am. J. Physiol. 37, F357-F362.
14. Lajeunesse, D., Meyer, R.A., Hamel, L., 1996. Direct demonstration of a humorally-mediated inhibition of renal phosphate transport in the Hyp mouse. Kidney Int. 50, 1531-1538.
15. Lau, K., Stom, M.C., Goldberg, M., Goldfarb, S., Gray, R.W., Lemann, J., Agus, Z.S., 1979. Evidence for a humoral phosphaturic factor in oncogenic hypophosphatemic osteomalacia. Clin. Res. 27, 421A.
16. Meyer, R.A. Jr., Meyer, M.H., Gray, R.W., Bruns, M.E., 1995. Femoral abnormalities and vitamin D metabolism in X-linked hypophosphatemic (Hyp and Gy) mice. J. Orthop. Res. 13, 30-40.
17. Meyer, R.A. Jr., Meyer, M.H., Gray, R.W., 1989a. Parabiosis suggests a humoral factor is involved in X-linked hypophosphatemia in mice. J. Bone Miner. Res. 4, 493-500.
18. Meyer, R.A. Jr., Tenenhouse, H.S., Meyer, M.H., Klugerman, A.H., 1989b. The renal phosphate transport defect in normal mice parabiosed to X-linked hypophosphatemic mice persists after parathyroidectomy. J. Bone Miner. Res. 4, 523-532.
19. Miyauchi, A., Fukase, M., Tsutsumi, M., Fujita, T., 1988. Hemangiopericytoma-induced osteomalacia: tumor transplantation in nude mice causes hypophosphatemia and tumor extracts inhibit renal 25-hydroxyvitamin D 1-hydroxylase activity. J. Clin. Endocrinol. Metab. 67, 46-53.
20. Nelson, A.E., Namkung, H.J., Patava, J., Wilkinson, M.R., Chang, A.C.-M., Reddel, R.R., Robinson, B.C., Mason, R.S., 1996. Characteristics of tumor cell bioactivity in oncogenic osteomalacia. Mol. Cell. Endocrinol. 124, 17-23.